PfizerPFE
近期动态
这件事怎么走
谁付钱给它
Blackstone 与 Pfizer 签下的合同金额最多约 15 亿美元。
“NEW YORK & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and Blackstone Life Sciences (“Blackstone”) today announced a strategic co-funding agreement under which funds managed by Blackstone will pay up to a total of $1.5 billion of development costs through 2028 for berobenatide, an investigational, potential first-in-class monthly GLP-1 receptor agonist peptide being studied for chr”
资料来源
- 辉瑞与星锐医药就自身免疫疾病签订独家许可协议,2026-11-18
- 英文虎报:辉瑞以最高 26 亿美元的交易从中国星锐医药获得 CAR-T 疗法许可,2026-11-18
- Newsquawk SMIC (981 HK) Q3 2026 (USD): Revenue 3.91bln (prev. 3bln Y/Y), Net Income 428.4mln (exp. 423mln),2026-11-12
- Pfizer · FinancialContent - Pfizer Enters into Exclusive Licensing Agreement with Starna Therapeutics for Autoimmune Diseases,2026-11-18
- Pfizer and Blackstone Life Sciences Announce Strategic Funding Agreement for Obesity Program,2026-11-11